Unlike currently approved weight loss medications, retatrutide works as a triple agonist, meaning it targets three different hormone receptors: GIP, GLP-1, and glucagon receptors
Your doctor will help determine if this approach fits your goals and needs
pregnancy test first, then assessment of whether caloric intake is adequate Management: provider evaluation required The estrogen-release phenomenon: why fat loss floods your system This is the mechanism most patients and many providers underestimate
In this interview, Michael Weintraub, MD, discusses key findings from studies of retatrutide, survodutide, oral GLP-1 receptor agonists, and amylin-based therapies
Joint and muscle pain, of varying intensities, may also occur
How much weight can you lose with GLP-1 medication